Muutke küpsiste eelistusi

Pharmaceutical Computer Systems Validation: Volume 2 - Real Life Case Studies 3rd edition [Kõva köide]

Edited by
  • Formaat: Hardback, 488 pages, kõrgus x laius: 254x178 mm, 36 Tables, black and white; 1 Line drawings, color; 97 Line drawings, black and white; 1 Halftones, color; 15 Halftones, black and white; 2 Illustrations, color; 112 Illustrations, black and white
  • Sari: Drugs and the Pharmaceutical Sciences
  • Ilmumisaeg: 23-Jun-2026
  • Kirjastus: CRC Press
  • ISBN-10: 1041371152
  • ISBN-13: 9781041371151
  • Kõva köide
  • Hind: 194,62 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 259,50 €
  • Säästad 25%
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 488 pages, kõrgus x laius: 254x178 mm, 36 Tables, black and white; 1 Line drawings, color; 97 Line drawings, black and white; 1 Halftones, color; 15 Halftones, black and white; 2 Illustrations, color; 112 Illustrations, black and white
  • Sari: Drugs and the Pharmaceutical Sciences
  • Ilmumisaeg: 23-Jun-2026
  • Kirjastus: CRC Press
  • ISBN-10: 1041371152
  • ISBN-13: 9781041371151
Computerized systems play a fundamental role in the development, manufacture, and supply of medical treatments. This is the third and thoroughly updated edition of the bestselling book dealing with validation and compliance of computer systems and software in the pharmaceutical, healthcare, and medical device industries.

Covers governance framework, roles and responsibilities, quality culture, project lifecycle, operational compliance, risk management, electronic records/signatures, supplier management, practical troubleshooting, handling regulatory inspections, metrics, and the opportunity for performance improvement.

Provides a set of 22 new and updated case studies by industry experts, demonstrating how these computer system validation principles are put into practice.

Focuses on GxP regulatory requirements covering GCPs, GLPs, GMPs, and GDPscomplete with observations from inspections by the US FDA and other regulators.

Discusses industry regulations and guidance, including current thinking of the US FDA on computer software assurance, the latest guidance from the US FDA/EU/MHRA on data integrity, and the newly published ISPE GAMP 5 Guide (Second Edition).

Shares the practical experience and advice from a group of leading computer validation and compliance international experts.

This edition of the book is split into two volumes. The first volume provides a comprehensive walkthrough of lifecycle and development methodologies, bringing together technological advances, the latest regulatory requirements, inspection findings, and compliance strategies. New chapters have been added on agile development methodologies, data integrity, artificial intelligence, and machine learning. The growing role of cloud computing services and IT tools is also discussed. The second volume comprises an extensive set of refreshed case studies spanning laboratory, manufacturing, and supply chain systems, authored by various industry experts, with new contributions on databases, spreadsheets, blockchain, mobile devices, AIenabled systems, data lakes and digital twins.

This is the second of two volumes making up this book. The first volume is available from the same publisher as a companion to this volume.
Foreword. Preface. List of Contributors. About The Editor.
Abbreviations.
Chapter 1: Case Study 1: Clinical Systems.
Chapter 2: Case
Study 2: Computerized Analytical Laboratory Systems.
Chapter 3: Case Study 3:
Chromatography Data Systems.
Chapter 4: Case Study 4: Laboratory Information
Management Systems.
Chapter 5: Case Study 5: Process Instrumentation.
Chapter
6: Case Study 6: Process Control Systems (Operational Technologies: OT).
Chapter 7: Case Study 7: Process Analytical Technology.
Chapter 8: Case Study
8: Manufacturing Execution Systems and Electronic Batch Records.
Chapter 9:
Case Study 9: Building Management Systems.
Chapter 10: Case Study 10:
Spreadsheets.
Chapter 11: Case Study 11: Database Applications.
Chapter 12:
Case Study 12: Electronic Document Management Systems.
Chapter 13: Case Study
13: Enterprise Resource Planning Systems.
Chapter 14: Case Study 14:
Marketing and Supply Applications.
Chapter 15: Case Study 15: IT
Infrastructure and Associated Services.
Chapter 16: Case Study 16: Big Data
Management.
Chapter 17: Case Study 17: Web-based Applications.
Chapter 18:
Case Study 18: Blockchain.
Chapter 19: Case Study 19: Mobile Devices.
Chapter
20: Case Study 20: Medical Devices and Their Automated Manufacture.
Chapter
21: Case Study 21: AI-enabled Computerized System.
Chapter 22: Case Study 22:
Blood Establishment Computer Systems. Glossary. Index
Guy Wingate, Ph.D., was VicePresident of Compliance and before that Director of Global Computer Validation at GlaxoSmithKline until his recent retirement. A wellknown speaker on computer validation, he has over 30 years of experience in the pharmaceutical industry. He has been a visiting lecturer at the University of Manchesters M.Sc. in Pharmaceutical Engineering Advanced Training program and the Dublin Institute of Technologys accredited M.Sc. in Validation Science program. He is an active member of the ISPE and served as Chair of the GAMP® Council for 10 years, which is responsible for the internationally recognized suite of GAMP® Guides on computer compliance. Guy led the teams who produced the original GAMP®5 Guide: A Risk Based Approach to Compliant GxP Computerized Systems and the GAMP® Good Practice Guide: A Risk-Based Approach to Compliant Electronic Records and Signatures. His extensive list of published work also includes the books Validating Automated Manufacturing and Laroratoty Applications, Validating Corporate Computer Systems and previous editions of this book, Pharmaceutical Computer Systems Validation.